We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

172 hedge funds and large institutions have $802M invested in Meridian Bioscience Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 56 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more call options, than puts

Call options by funds: $2.38M | Put options by funds: $1.05M

32% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 56

1% less capital invested

Capital invested by funds: $807M → $802M (-$4.82M)

2% less funds holding

Funds holding: 176 → 172 (-4)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

Holders
172
Holders Change
-4
Holders Change %
-2.27%
% of All Funds
4.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
74
Reduced
56
Closed
19
Calls
$2.38M
Puts
$1.05M
Net Calls
+$1.33M
Net Calls Change
+$728K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$8.27M
2
Norges Bank
Norges Bank
Norway
+$6.96M
3
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$5.28M
4
BTW
Boston Trust Walden
Massachusetts
+$4.75M
5
FAM
Fred Alger Management
New York
+$4.41M

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$11.6M
2
PP
Prudential plc
United Kingdom
-$9.97M
3
Wells Fargo
Wells Fargo
California
-$6.96M
4
FAM
Fenimore Asset Management
New York
-$5.44M
5
WBC
Westpac Banking Corp
Australia
-$4M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.89M -$53.9K -2,737 -1%
CAM
27
Capstone Asset Management
Texas
$4.74M +$4.26M +216,115 +1,560%
FAM
28
Fred Alger Management
New York
$4.61M +$4.41M +223,740 New
NFA
29
Nationwide Fund Advisors
Ohio
$4.35M -$5.93K -301 -0.1%
GF
30
Gabelli Funds
New York
$4.2M +$78.8K +4,000 +2%
Ameriprise
31
Ameriprise
Minnesota
$4.18M -$17K -865 -0.4%
Wells Fargo
32
Wells Fargo
California
$3.98M -$6.96M -353,288 -65%
GAM
33
Gotham Asset Management
New York
$3.53M +$1.67M +84,701 +98%
BIM
34
BlackRock Investment Management
Delaware
$3.37M +$31.9K +1,618 +1%
PAM
35
Panagora Asset Management
Massachusetts
$3.36M -$353K -17,928 -10%
CIS
36
Connors Investor Services
Pennsylvania
$3.13M +$7.82K +397 +0.3%
New York State Teachers Retirement System (NYSTRS)
37
New York State Teachers Retirement System (NYSTRS)
New York
$3.09M +$55.2K +2,800 +2%
AI
38
Analytic Investors
California
$2.89M +$2.31M +117,391 +515%
GI
39
GAMCO Investors
Connecticut
$2.88M – – –
TA
40
Teton Advisors
New York
$2.88M +$39.4K +2,000 +1%
TCIM
41
TIAA CREF Investment Management
New York
$2.8M -$66.9K -3,394 -2%
MIP
42
Mondrian Investment Partners
United Kingdom
$2.73M +$2.58M +130,780 +8,128%
Citadel Advisors
43
Citadel Advisors
Florida
$2.68M +$644K +32,689 +34%
HighTower Advisors
44
HighTower Advisors
Illinois
$2.52M +$2.41M +122,315 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$2.5M +$71.1K +3,610 +3%
ZAM
46
Zevin Asset Management
Massachusetts
$2.48M +$24.8K +1,260 +1%
PCM
47
Piermont Capital Management
Missouri
$2.45M -$57.3K -2,910 -2%
PPA
48
Parametric Portfolio Associates
Washington
$2.41M +$774K +39,258 +51%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$2.34M +$407K +20,641 +22%
RC
50
Randolph Company
Ohio
$2.21M – – –
1
2
3 4 5

VIVO Hedge Fund Activity: Q1 2016 in Review

172 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2016, worth a combined $802M — down 0.6% from $807M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of VIVO and 17 opened new positions — a net loss of 2 holders — while 56 trimmed existing stakes and 74 added.

The largest buyer was Acadian Asset Management, adding an estimated $8.27M. The largest seller was Neuberger Berman Group, cutting an estimated $11.6M.

  • 172 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2016, down from 176 in Q4 2015.
  • Funds reported $802M of Meridian Bioscience Inc stock for Q1 2016, down 0.6% quarter-over-quarter.
  • 17 funds opened new Meridian Bioscience Inc positions in Q1 2016 and 19 closed out, a net change of -2 holders.
  • The largest Meridian Bioscience Inc buyer in Q1 2016 was Acadian Asset Management, an estimated $8.27M added.
  • The largest Meridian Bioscience Inc seller in Q1 2016 was Neuberger Berman Group, an estimated $11.6M sold.

Based on aggregated 13F filings for Q1 2016.